Two Sigma Securities’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$130K Buy
+81,044
New +$154K 0.01% 1274
2026
Q1
– Sell
-12,230
Closed -$16.8K – 1628
2025
Q4
$16.8K Sell
12,230
-10,895
-47% -$14.4K ﹤0.01% 1203
2025
Q3
$28.7K Buy
23,125
+86
+0.4% +$103 ﹤0.01% 1075
2025
Q2
$26K Buy
+23,039
New +$30.6K ﹤0.01% 1170

Other funds holding ALLO

Two Sigma Securities's ALLO Position: Q3 2026 in Review

Two Sigma Securities opened a new position in Allogene Therapeutics (ALLO) in Q3 2026: 81,044 shares worth $130K. The stake represents 0.01% of the portfolio and ranks #1274 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in ALLO as recently as Q4 2025.

Two Sigma Securities first reported a position in ALLO in Q2 2025 and has held it in 4 quarters since. 198 funds tracked by Wall St. Rank hold ALLO as of Q3 2026.

  • Two Sigma Securities held 81,044 shares of Allogene Therapeutics worth $130K as of Q3 2026.
  • Allogene Therapeutics was a new Two Sigma Securities position in Q3 2026.
  • Allogene Therapeutics made up 0.01% of Two Sigma Securities's portfolio in Q3 2026, its #1274 holding.
  • Two Sigma Securities first reported a position in Allogene Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 198 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q3 2026.

Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.